Smith+Nephew, the FTSE‑100 medical technology company, completed the first clinical cases using its next‑generation CORI XT handheld robotics platform across both knee and shoulder arthroplasty, which the company calls the first robotic shoulder arthroplasty procedures globally in hospital and ambulatory surgery centre settings.
The CORI XT is positioned as a single handheld robotics platform for partial to revision knee, hip* and anatomic and reverse shoulder procedures, with a compact footprint for hospitals and ASCs, and Smith+Nephew said the initial cases were performed at Duke Health, North Valley Surgery Center in Scottsdale and NYU Langone.
"The CORI SHOULDER workflow was streamlined and efficient; registration and planning were seamless; and the post‑op x‑rays matched our pre‑op planning," said Dr Christopher Klifto of Duke Health.
CORI SHOULDER was used alongside Smith+Nephew’s AETOS Shoulder System and supports handheld robotic execution of the humerus and glenoid for anatomic and reverse procedures while integrating with the CORIOGRAPH pre‑operative planning and modelling services.
Smith+Nephew says the platform is part of its Skill Amplified approach to enhance surgical accuracy while preserving surgeon control and forms part of its MTECH portfolio of robotics, navigation and visualization technologies.
The company described these early procedures as an important milestone in the platform’s broader rollout as its applications continue to expand and noted the CORI HIP indication is under development.
